CD34 and chronic myelogenous leukemia, BCR-ABL1 positive: Although global gene expression patterns in the CML and normal CD34+CD38−ALDHhigh cells were fairly similar, gene-level analysis allowed us to identify several genes with significant differential expression that may serve as therapeutic targets.